ChineseInvestors.com, Inc. (OTCQB: CIIX) (“CIIX” or “the Company”), an established financial news and investment portal and a leading industrial hemp retailer for the Chinese-speaking community, today announced that its subsidiary CBD Biotech, Inc., an exempted company with limited liability incorporated in the Cayman Islands (“CBD Biotech”) will attend the “2019 China Industrial Cannabis Investment Seminar” on October 31, 2019 in Shanghai, China and the “2019 China Industrial Cannabis CBD Industry International Conference” on November  23-24, 2019, in Haerbing, China.

These conferences are attended by companies and executives in China who are active in the industrial hemp market, like CBD Biotech, or have plans to enter the market in the near future, foreign industrial hemp companies, and institutional investors, secondary market institutional investors, and other high net worth investors interested in the industry.

CBD Biotech executives will be available at each of the upcoming conferences to provide information and education on its industrial hemp-infused skincare and cosmetic products, its hemp wine, and to discuss its strategic plans for future development. Slated to launch two new industrial hemp products soon, CBD Biotech will also feature its new products at these conferences.

Although the industrial hemp skincare and cosmetics industry is still in the early stages of development in China, as a first mover in this market, CBD Biotech has already laid the foundation to capitalize on this growing industry. It is legal in China to add industrial hemp/CBD extract to cosmetics, creating potential market of nearly 1.4 billion people for hemp-infused/CBD skincare and cosmetics.

SOURCE ChineseInvestors.com, Inc.